Top Markets
Coin of the day
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Rankning i aktier #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Aktiekurs
$0.32276013
Senast synkroniserad: 2026-08-17
Marknadsvärde
$25.60M
Förändring (1 dag)
0.00%
Förändring (1 år)
-38.97%
Land
TW
Handel MegaPro Biomedical Co., Ltd (6827)

Kategori

Aktiekurshistorik för MegaPro Biomedical Co., Ltd (6827)
Högsta slutkurs: $0.32 den 2026-08-01

Lägsta slutkurs: $1.16 den 2021-10-01
Aktiekurshistorik för MegaPro Biomedical Co., Ltd från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 5.54%
2025 -10.48%
2024 -45.13%
2023 34.29%
2022 -46.18%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH